E.E. Geduld’s Filana Therapeutics FLNA Stock Holding History

E.E. Geduld’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-3,571	Closed	-$138K	–	331
2014 Q1	$138K	Buy	+3,571	New	+$126K	0.07%	210

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

MSP

Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

E.E. Geduld's FLNA Position: Q2 2014 in Review

E.E. Geduld sold out of Filana Therapeutics (FLNA) in Q2 2014, closing a stake of 3,571 shares — an estimated $138K sold.

E.E. Geduld first reported a position in FLNA in Q1 2014 and held it in 1 quarter. The position peaked at $138K in Q1 2014. 87 funds tracked by Wall St. Rank hold FLNA as of Q2 2014.

E.E. Geduld reported no remaining Filana Therapeutics position as of Q2 2014 after selling out during the quarter.
E.E. Geduld sold 3,571 Filana Therapeutics shares in Q2 2014, an estimated $138K.
E.E. Geduld first reported a position in Filana Therapeutics in Q1 2014 and held it in 1 quarter.
E.E. Geduld's Filana Therapeutics position peaked at $138K in Q1 2014.
87 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2014.

Based on E.E. Geduld's 13F filing for Q2 2014, filed 4 Aug 2014.